Springer Nature OAopen access
Cost–Effectiveness Analysis of Bimekizumab against Interleukin-23 Inhibitors in Patients with Plaque Psoriasis in Japan
Medicine & Public Health, Internal Medicine, Dermatology, Plastic Surgery, Oral and Maxillofacial Surgery, Quality of Life Research
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 299093
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.